MedPath

Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography

Completed
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
Device: EIM Measurements
Registration Number
NCT01803386
Lead Sponsor
Skulpt, Inc.
Brief Summary

The purpose of this protocol is to test a new Electrical Impedance Myography (EIM) device and study its reliability and ability to differentiate ALS patients from healthy controls.

Detailed Description

Investigators will study 10 ALS patients and at least 10 age-matched healthy controls between the ages of 21 and 85 years old. For all subjects, EIM measurements will be performed on four muscles: two in the upper and two in the lower extremities, using 8 different EIM sensors. Measurements will be repeated one time.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Diagnosis of probable or definite ALS by the El Escorial Criteria
Exclusion Criteria
  • History of superimposed generalized neuromuscular disease
  • Primary lateral sclerosis or other atypical motor neuron disorders
  • Forced vital capacity of less than 50%
  • Presence of disease for greater than 5 years since symptom onset

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ALS SubjectsEIM MeasurementsEIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. The ALSFRS-R will also be administered. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers.
Healthy SubjectsEIM MeasurementsEIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers.
Primary Outcome Measures
NameTimeMethod
Muscle health as captured by EIM measurementsOne time visit - Day 1

EIM measurements will be performed with several electrode arrays at one visit per patient. The data captured from ALS and healthy subjects will be used to refine and finalize electrode array design development for the EIM system.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Convergence Medical Devices

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath